These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 6217639)

  • 21. [Nature of lytic effect of fibrinogen-heparin and thyroxine-heparin complexes on fibrin].
    Kudriashov BA; Liapina LA; Molchanova LV; Rustamova BA
    Vopr Med Khim; 1970; 16(2):161-8. PubMed ID: 4247358
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on soluble fibrin in plasma. II. N-terminal analysis of a modified fraction I (Cohn) from patient plasmas.
    Kierulf P
    Scand J Clin Lab Invest; 1973 Jan; 31(1):37-42. PubMed ID: 4265796
    [No Abstract]   [Full Text] [Related]  

  • 23. [Enzymatic and nonenzymatic fibrinolysis in various kidney diseases].
    Sokratov NV
    Ter Arkh; 1983; 55(6):55-8. PubMed ID: 6193598
    [No Abstract]   [Full Text] [Related]  

  • 24. Fibrinogen adsorption, platelet adhesion and thrombin generation at heparinized surfaces exposed to flowing blood.
    Keuren JF; Wielders SJ; Willems GM; Morra M; Lindhout T
    Thromb Haemost; 2002 Apr; 87(4):742-7. PubMed ID: 12008960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation of the anti-factor VIII effect of thrombin in plasma by the plasminolytic derivatives of fibrinogen and fibrin.
    Chandra S; Triantaphyllopoulos DC
    Thromb Diath Haemorrh; 1973 Nov; 30(2):235-47. PubMed ID: 4272616
    [No Abstract]   [Full Text] [Related]  

  • 26. [Nonenzymatic fibrinolysis in patients with ischemic heart disease].
    Panchenko VM; Liapina LA
    Kardiologiia; 1974 Nov; 14(11):14-8. PubMed ID: 4279308
    [No Abstract]   [Full Text] [Related]  

  • 27. Surface-adsorbed fibrinogen and fibrin may activate the contact activation system.
    Sanchez J; Elgue G; Larsson R; Nilsson B; Olsson P
    Thromb Res; 2008; 122(2):257-63. PubMed ID: 18177925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative determination of fibrin and fibrinogen in biological material.
    Haeberli A; Straub PW
    J Lab Clin Med; 1980 Aug; 96(2):258-66. PubMed ID: 6447180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the mechanism of enhanced thromboresistance of polymeric materials in the presence of heparin.
    Platé NA; Valuev LI
    Biomaterials; 1983 Jan; 4(1):14-20. PubMed ID: 6838953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inactivation of hemostatic factors by hematin.
    Green D; Reynolds N; Klein J; Kohl H; Ts'ao CH
    J Lab Clin Med; 1983 Sep; 102(3):361-9. PubMed ID: 6411843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein adsorption on polyurethane catheters modified with a novel antithrombin-heparin covalent complex.
    Du YJ; Brash JL; McClung G; Berry LR; Klement P; Chan AK
    J Biomed Mater Res A; 2007 Jan; 80(1):216-25. PubMed ID: 17072855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin].
    Kudriashov BA; Pastorova VE; Liapina LA
    Biokhimiia; 1981 Nov; 46(11):2024-9. PubMed ID: 7317530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
    Bremme K; Lind H; Blombäck M
    Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [An analysis of a disorder in the fibrin-forming phase in virtually healthy middle-aged and elderly subjects by using the ancistron test].
    Platonova TN; Sushko OO; Lukinova NI; Solovĭov DA
    Fiziol Zh (1994); 1994; 40(3-4):63-70. PubMed ID: 7621957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnosis and therapy of consumption coagulopathy].
    Lechner K
    Wien Klin Wochenschr; 1973 Jun; 85(26):467-70. PubMed ID: 4268703
    [No Abstract]   [Full Text] [Related]  

  • 36. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
    Niwa K; Mimuro J; Miyata M; Sugo T; Ohmori T; Madoiwa S; Tei C; Sakata Y
    Thromb Res; 2008; 121(6):773-80. PubMed ID: 17854865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Action of an adrenaline-heparin complex on the blood in vivo].
    Liapina LA; Balakina TA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1974; 5():38-42. PubMed ID: 4275517
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of heparin on the activation of factor XI by fibrin-bound thrombin.
    von dem Borne PA; Meijers JC; Bouma BN
    Thromb Haemost; 1996 Sep; 76(3):347-53. PubMed ID: 8883269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of soluble fibrin monomer complexes by adsorption on immobilized fibrinogen.
    Stemberger AW; Hörmann H
    Thromb Haemost; 1978 Jun; 39(3):574-81. PubMed ID: 568324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Turbidimetric analysis of fibrin polymerization in the plasma].
    Shcherbak IG; Subbotina TF; Faenkova VP; Riumina EV
    Vopr Med Khim; 2001; 47(1):80-90. PubMed ID: 11386001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.